International Flavors & Fragrances IFF Pharma Solutions — Current associated costs
Discontinued — last reported Q4 '21
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:MalpracticeLossContingencyPeriodCost.
The official record: International Flavors & Fragrances’s 10-K, filed February 28, 2022, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's pharma solutions — current associated costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is International Flavors & Fragrances's pharma solutions — current associated costs?
- International Flavors & Fragrances (IFF) reported pharma solutions — current associated costs of $5.25M in Q4 2021.
- What does pharma solutions — current associated costs mean?
- The immediate, non-recurring costs associated with operating and maintaining the pharmaceutical solutions business.
- How do you interpret pharma solutions — current associated costs?
- An increase may signal rising regulatory compliance burdens or operational inefficiencies, while a decrease suggests improved operational discipline or reduced project-related overhead.
- How does pharma solutions — current associated costs compare across companies?
- Similar to 'other operating expenses' or 'non-recurring segment charges' found in the segment reporting of diversified chemical and pharma companies.